Immatics (IMTX) Cash from Discontinued Operations (2020 - 2024)
Immatics' (IMTX) quarterly Cash from Discontinued Operations came in at 37041845.6 in Q3 2024, down 11.47% year-on-year from 41841031.88 in Q4 2023, and down 11.47% quarter-over-quarter from 33230312.89 in Q3 2023.
Immatics (IMTX) Cash from Discontinued Operations (2020 - 2024) Analysis & Trends
Immatics has disclosed Cash from Discontinued Operations across 5 years of filings, most recently posting 37041845.6 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2022 | -32.41 Bn |
| Sep 30, 2022 | -32.41 Bn |
| Jun 30, 2022 | 58.28 Bn |
| Jun 30, 2022 | 58.28 Bn |
| Mar 31, 2022 | 122.45 Bn |
| Mar 31, 2022 | 122.45 Bn |
| Jun 30, 2021 | 24.02 Bn |
| Jun 30, 2021 | 24.02 Bn |
| Mar 31, 2021 | 20.09 Bn |
| Mar 31, 2021 | 20.09 Bn |
| Jun 30, 2020 | -17.94 Bn |
| Jun 30, 2020 | -17.94 Bn |
| Mar 31, 2020 | -12.64 Bn |
| Mar 31, 2020 | -12.64 Bn |